The Dossier
Subscribe
Sign in
Share this post
Same junk, different name: Novavax will pursue indefinite boosting, and there's no trial data on Omicron
dossier.substack.com
Copy link
Twitter
Facebook
Email
Same junk, different name: Novavax will…
Jordan Schachtel
Jun 8, 2022
182
45
Share this post
Same junk, different name: Novavax will pursue indefinite boosting, and there's no trial data on Omicron
dossier.substack.com
Copy link
Twitter
Facebook
Email
Prior to COVID Mania, Novavax and its competitors had never brought a product to market
Read →
Top First
New First
Chronological
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Same junk, different name: Novavax will pursue indefinite boosting, and there's no trial data on Omicron
Same junk, different name: Novavax will…
Same junk, different name: Novavax will pursue indefinite boosting, and there's no trial data on Omicron
Prior to COVID Mania, Novavax and its competitors had never brought a product to market